ghk-cu biostrips | Research Grade Peptide GHK-CU for Sale | Tripeptide-1

Only one Phase I clinical trial has been registered, and no Phase 2 or 3 trials have been completed

Severe allergic reactions are very rare and almost exclusively associated with injectable rather than oral B12

Sikiric P, Seiwerth, S, Grabarevic Z, et al

To achieve a higher throughput data collection, aberration-free image shift (AFIS) was used as implemented in the Thermo EPU software package

The common standalone ladder starts at 0.25 mg once weekly, escalates every 4 weeks, and reaches a 2.4 mg weekly research-target dose from week 17 onward

Our GHK-Cu formula is compatible with most hair loss protocols and can be used alongside other topicals or treatments without issue